Filing Details
- Accession Number:
- 0001209191-20-041557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-07 19:18:12
- Reporting Period:
- 2020-07-02
- Accepted Time:
- 2020-07-07 19:18:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1596492 | Herve Hoppenot | 1801 Augustine Cut-Off Wilmington DE 19803 | Chairman / Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-02 | 39,059 | $0.00 | 279,662 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-07-02 | 11,602 | $106.47 | 268,060 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-07-06 | 1,559 | $107.79 | 266,501 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-07-07 | 1,365 | $73.21 | 267,866 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-07 | 1,365 | $110.00 | 266,501 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-07 | 88,406 | $73.21 | 354,907 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-07 | 88,406 | $110.00 | 266,501 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2020-07-02 | 74,720 | $0.00 | 74,720 | $106.47 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-07-07 | 1,365 | $0.00 | 1,365 | $73.21 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-07 | 88,406 | $0.00 | 88,406 | $73.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 74,720 | 2030-07-01 | No | 4 | A | Direct | |
| 0 | 2022-01-07 | No | 4 | M | Direct | |
| 0 | 2022-01-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 66,234 | Indirect | By GRAT |
| Common Stock | 66,234 | Indirect | By GRAT |
| Commont Stock | 66,234 | Indirect | By GRAT |
| Common Stock | 66,234 | Indirect | By GRAT |
| Common Stock | 66,234 | Indirect | By GRAT |
| Common Stock | 66,234 | Indirect | By GRAT |
| Common Stock | 66,234 | Indirect | By GRAT |
Footnotes
- Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Herve Hoppenot's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or performance shares previously reported in Table I as common stock.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 118,371 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
- On June 15, 2018, the reporting person contributed 103,033 shares to a grantor retained annuity trust (GRAT). On June 17, 2019, 20,407 shareswere distributed by the GRAT to the reporting person in accordance with the terms of the GRAT and continue to be reported in this Form 4 asdirectly owned. In addition, on June 2, 2020 an additional 16,392 were distributed by the GRAT to the reporting person in accordance with theterms of the GRAT and continue to be reported in this Form 4 as directly owned.
- Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
